Literature DB >> 7826854

Roles of DNA topoisomerases in chromosomal replication and segregation.

J L Nitiss1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7826854     DOI： 10.1016/s1054-3589(08)60542-6

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  12 in total

1.  Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.

Authors:  M Takei; H Fukuda; R Kishii; M Hosaka
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Assessing sensitivity to antibacterial topoisomerase II inhibitors.

Authors:  Sonia K Morgan-Linnell; Hiroshi Hiasa; Lynn Zechiedrich; John L Nitiss
Journal:  Curr Protoc Pharmacol       Date:  2007-12

3.  Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.

Authors:  A Das; A Dasgupta; S Sharma; M Ghosh; T Sengupta; S Bandopadhyay; H K Majumder
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

4.  Design and development of topoisomerase inhibitors using molecular modelling studies.

Authors:  Muthu K Kathiravan; Madhavi M Khilare; Aparna S Chothe; Madhuri A Nagras
Journal:  J Chem Biol       Date:  2012-09-29

5.  Structure and conformational changes of DNA topoisomerase II visualized by electron microscopy.

Authors:  P Schultz; S Olland; P Oudet; R Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

6.  Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.

Authors:  Q Wang; G P Zambetti; D P Suttle
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

Review 7.  Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action.

Authors:  M E Cardenas; M C Cruz; M Del Poeta; N Chung; J R Perfect; J Heitman
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 8.  Fibrates in the chemical action of daunorubicin.

Authors:  Ganesaratnam K Balendiran
Journal:  Curr Cancer Drug Targets       Date:  2009-05       Impact factor: 3.428

9.  Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.

Authors:  M Takei; H Fukuda; T Yasue; M Hosaka; Y Oomori
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

10.  Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.

Authors:  K N Meyer; E Kjeldsen; T Straub; B R Knudsen; I D Hickson; A Kikuchi; H Kreipe; F Boege
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.